Pharmaceutical News and Articles

Inhaled Insulin Could Help Folks With Type 1 Diabetes Avoid Needles

Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows.Patients using inhaled insu

Twice-a-Year Injection Gives Women Full Protection Against HIV, Trial Finds

an injection just twice a year is the option that could keep her free of HIV, Lillian Mworeko, who leads a group called the International Community of Women Liv

Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of Krazati (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)

Dad Facts: What Men Need to Know About Their Fertility

rather, it happens little by little. Guys who are obese or who put on weight may also have trouble producing enough sperm. A doctor might recommend losing weigh

Plane Hygiene: Staying Healthy at 35,000 Feet

seats, tray tables, seat back pockets, arm rests, flight attendant call buttons, air vents and lavatory door handlesApply hand sanitizer or wash your hands regu

GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea

A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.The worldwide clinical trial demonstrates that tirzepatide signific

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal disease an

FDA Approves KEYTRUDA + Chemo for Primary Advanced, Recurrent Endometrial Carcinoma

The U.S. Food and Drug Administration has approved Keytruda (pembrolizumab) plus chemotherapy as treatment for adult patients with primary advanced or recurrent

Social Anxiety Tied to Later Risk for Suicidal Ideation, Depression

Baseline social anxiety symptoms are associated with two-year suicidal ideation and depressive symptoms, according to a study published online June 10 in JCPP A

FDA Expands Pediatric Indication for Rinvoq

The U.S. Food and Drug Administration has expanded indications for Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyart